Robert Jenkins

Array ( [id] => 9944416 [patent_doc_number] => 08993717 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Gadd45beta targeting agents' [patent_app_type] => utility [patent_app_number] => 13/502781 [patent_app_country] => US [patent_app_date] => 2010-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 41 [patent_no_of_words] => 44300 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 389 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13502781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394161 [patent_doc_number] => 20120231999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'PEPTIDIC GLP-2 AGONISTS' [patent_app_type] => utility [patent_app_number] => 13/503010 [patent_app_country] => US [patent_app_date] => 2010-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11228 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968616 [patent_doc_number] => 08507427 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Structural and mechanistic basis for novel compound biosynthesis using the 4-electron hexose oxidase' [patent_app_type] => utility [patent_app_number] => 12/896747 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8093 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12896747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381464 [patent_doc_number] => 20120225087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'NICOTINE HAPTENS, IMMUNOCONJUGATES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/261217 [patent_app_country] => US [patent_app_date] => 2010-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11274 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8370184 [patent_doc_number] => 20120219573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'DISULFIDE-LINKED POLYETHYLENEGLYCOL/PEPTIDE CONJUGATES FOR THE TRANSFECTION OF NUCLEIC ACIDS' [patent_app_type] => utility [patent_app_number] => 13/378241 [patent_app_country] => US [patent_app_date] => 2010-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 45418 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13378241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8251968 [patent_doc_number] => 20120156295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'ANTIBIOTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/393294 [patent_app_country] => US [patent_app_date] => 2010-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7635 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156295.pdf [firstpage_image] =>[orig_patent_app_number] => 13393294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371137 [patent_doc_number] => 20120220525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'Stablized Melanocortin Ligands' [patent_app_type] => utility [patent_app_number] => 13/389820 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6812 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6167144 [patent_doc_number] => 20110195898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'TREATMENT OF ALZHEIMER\'S DISEASE AND MILD COGNITIVE IMPAIRMENT USING GNRH-I ANALOGS AND ONE OR MORE OF ACETYLCHOLINESTERASE INHIBITORS AND NMDA RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/871008 [patent_app_country] => US [patent_app_date] => 2010-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30726 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195898.pdf [firstpage_image] =>[orig_patent_app_number] => 12871008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465606 [patent_doc_number] => 20120270774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'MACROCYCLIC COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS FOR PREVENTING OR TREATING HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 13/392846 [patent_app_country] => US [patent_app_date] => 2010-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15937 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8394406 [patent_doc_number] => 20120232247 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-13 [patent_title] => 'PROCESSES FOR PREPARING PROTEASE INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 13/392168 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 22051 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371364 [patent_doc_number] => 20120220753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'N-Terminal Dimerization Methods with Bis-Amindino Acid and Bis-Thioimidate Derivatives' [patent_app_type] => utility [patent_app_number] => 13/392606 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2073 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401701 [patent_doc_number] => 08691753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Pseudodipeptides as MMP inhibitors' [patent_app_type] => utility [patent_app_number] => 13/392358 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23371 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286219 [patent_doc_number] => 08642548 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome' [patent_app_type] => utility [patent_app_number] => 13/389410 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 18849 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10870302 [patent_doc_number] => 08895499 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'β-hairpin peptidomimetics' [patent_app_type] => utility [patent_app_number] => 13/814398 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31306 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 232 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951123 [patent_doc_number] => 20130196904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING MEDICAL CONDITIONS AND A METHOD FOR TREATING ALIMENTARY DISORDERS AND RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/388194 [patent_app_country] => US [patent_app_date] => 2010-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4691 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301940 [patent_doc_number] => 20120184496 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'OPHTHALMIC PHARMACEUTICAL COMPOSITIONS OF DP2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/387064 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25467 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387064 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8301938 [patent_doc_number] => 20120184493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'DERMAL FORMULATIONS OF DP2 RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/387047 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21625 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13387047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134383 [patent_doc_number] => 20110008285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'NOVEL CYCLOSPORIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/832357 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18956 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008285.pdf [firstpage_image] =>[orig_patent_app_number] => 12832357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134384 [patent_doc_number] => 20110008286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'NOVEL PROLINE SUBSTITUTED CYCLOSPORIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/832383 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18264 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008286.pdf [firstpage_image] =>[orig_patent_app_number] => 12832383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6134382 [patent_doc_number] => 20110008284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'NOVEL CLYCLOSPORIN ANALOGUES' [patent_app_type] => utility [patent_app_number] => 12/832316 [patent_app_country] => US [patent_app_date] => 2010-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18587 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008284.pdf [firstpage_image] =>[orig_patent_app_number] => 12832316 [rel_patent_id] =>[rel_patent_doc_number] =>)